HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 232
- Locations
- 1
- Primary Endpoint
- Viral load
Study Overview
Brief Summary
A clinical study for patients with HIV that investigates the best way to reduce HIV transmission risk, and to improve the overall health of people living with HIV/AIDS. Participants will complete four assessments over the course of one year and will be randomly assigned to a five-week treatment program.
Detailed Description
The main purpose of this research study is to investigate the best way to reduce HIV transmission risk and to improve the overall health of people living with HIV/AIDS. This study tests an intervention program that aims to improve knowledge, motivation, and skills. The intervention program is designed to motivate participants to take their medications routinely, improve the quality of life for those living with HIV, and decrease risky behaviors that may lead to HIV transmission.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •HIV positive
- •Recent alcohol use
Exclusion Criteria
- Not provided
Arms & Interventions
Standard of Care
Five-week standard of care program.
WELL Program
Five-week treatment program that aims to improve knowledge, motivation, and skills. It is designed to motivate participants to take their medications routinely, improve the quality of life for those living with HIV, and decrease risky behaviors that may lead to HIV transmission.
Intervention: WELL Program (Behavioral)
Outcomes
Primary Outcomes
Viral load
Time Frame: Change from baseline at 3 months, 6 months and 1 year
The primary outcome measure will be disease progression or more specifically, the proportion of patients achieving viral suppression.
Secondary Outcomes
No secondary outcomes reported
Investigators
Patricia Molina
Richard Ashman, PhD Professor and Head Department of Physiology; Director Alcohol and Drug Abuse Center of Excellence
Louisiana State University Health Sciences Center in New Orleans